molecular subtypes in diffuse large b-cell lymphoma
Published 9 years ago • 607 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
3:04
future directions for the treatment of diffuse large b-cell lymphoma
-
7:16
changes in the classification of dlbcl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
11:47
petscan results. warning...not what we hoped for.
-
9:09
my story: how i found out i have gray zone lymphoma
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
2:53
autohct in dlbcl in the car-t era
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:15
personalized medicine for dlbcl
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
2:19
latest updates in lymphoma trials
-
3:07
the role of bridging and timing in car-t
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
0:42
targeted therapies for dlbcl treatment
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
2:41
an overview of the latest advances in hematology
-
1:34
recent and upcoming data on axi-cel for patients with nhl
-
1:45
the importance of real-world data in cll & efficacy of btk and bcl-2 inhibitors in the real world
-
3:21
safety management of car-t cell therapy in dlbcl